Inflammatory Disease Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.
Another Biosimilar Gets a Green Light
The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.
Biologics Show Promise for Bowels
Biologic treatments for inflammatory bowel diseases may help heal the intestines, a new study found.
Green Light for Biosimilar to Humira
The US Food and Drug Administration has approved its fourth biosimilar.
Second Biosimilar Gets FDA Nod
The US Food and Drug Administration (FDA) has approved the second-ever biosimilar, and it's meant to treat multiple conditions that affect the immune system.
How Dermatologists Could Help IBD Patients
Skin lesions are a common but unpleasant side effect of the anti-TNF drugs often used to treat patients with inflammatory bowel disease (IBD). But discontinuing treatment is not recommended.
FDA Approves Rx to Treat Crohn's Disease in Kids
The US Food and Drug Administration (FDA) has approved a new treatment for Crohn's disease in children. It is the first treatment for pediatric Crohn's approved to be administered at home.
IBD Could Affect Your Heart
Inflammatory bowel diseases are serious conditions on their own. But they also can lead to life-threatening complications that may extend to organs beyond the digestive system — even to the heart.
Dental Problems Plague Crohn’s Patients
Some studies have shown Crohn’s disease patients to have more cavities and other dental problems. Are these problems related to the disease, dental hygiene or other risk factors?
Factors Behind Low Bone Density in IBD
Patients with inflammatory bowel disease have an increased risk of low bone density. Vitamin deficiency appears to be only one factor increasing the risk.